Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1A | P07327 | 3/20 | 0.35 |
| ▸ | ADH1C | P00326 | 2/20 | 0.35 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.32 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.32 |
| ▸ | FAAH | O00519 | 1/20 | 0.32 |
| ▸ | PHGDH | O43175 | 1/20 | 0.32 |
| ▸ | MGLL | Q99685 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17053504 | 0.98 | ADH1C (0.32) | ADH1AADH1C | |
| SCHEMBL17053524 | 0.86 | ADH1A (0.41) | ADH1AADH1CHRH4HRH3FAAH | |
| SCHEMBL16639191 | 0.84 | ADH1A (0.37) | ADH1AADH1CHRH4HRH3FAAH | |
| SCHEMBL17053526 | 0.84 | ADH1A (0.37) | ADH1AADH1CHRH4HRH3FAAH | |
| SCHEMBL17053550 | 0.82 | ADH1C (0.33) | ADH1AADH1CHRH4HRH3FAAH | |
| SCHEMBL17053517 | 0.80 | — | — | |
| SCHEMBL16582933 | 0.80 | — | — | |
| SCHEMBL17053573 | 0.79 | ADH1A (0.39) | ADH1AADH1CHRH4HRH3FAAH | |
| SCHEMBL16639179 | 0.78 | ADH1A (0.37) | ADH1AADH1C | |
| SCHEMBL27966761 | 0.77 | ADH1A (0.39) | ADH1AADH1CHRH4HRH3FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3395822-A1 | ORGANOAMINOSILANES AND METHODS FOR MAKING SAME | Versum Materials US, LLC (US) | 2018-10-31 | — | — | EP | disclosed |
| US-9758534-B2 | Organoaminosilanes and methods for making same | VERSUM MATERIALS US, LLC (US) | 2017-09-12 | — | — | US | disclosed |
| US-9758534-B2 | Organoaminosilanes and methods for making same | VERSUM MATERIALS US, LLC (US) | 2017-09-12 | — | — | US | disclosed |
| US-20170204120-A1 | Organoaminosilanes and Methods for Making Same | VERSUM MATERIALS US, LLC (US) | 2017-07-20 | — | — | US | disclosed |
| EP-3095788-A2 | ORGANOAMINOSILANE PRECURSORS AND METHODS FOR DEPOSITING FILMS COMPRISING SAME | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2016-11-23 | — | — | EP | disclosed |
| US-20160168169-A1 | ORGANOAMINOSILANES AND METHODS FOR MAKING SAME | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2016-06-16 | — | — | US | disclosed |
| US-20160168169-A1 | ORGANOAMINOSILANES AND METHODS FOR MAKING SAME | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2016-06-16 | — | — | US | disclosed |
| US-20160168169-A1 | ORGANOAMINOSILANES AND METHODS FOR MAKING SAME | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2016-06-16 | — | — | US | disclosed |
| US-9233990-B2 | Organoaminosilanes and methods for making same | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2016-01-12 | — | — | US | disclosed |
| US-9233990-B2 | Organoaminosilanes and methods for making same | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2016-01-12 | — | — | US | disclosed |
| US-20150246937-A1 | ORGANOAMINOSILANES AND METHODS FOR MAKING SAME | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2015-09-03 | — | — | US | disclosed |
| US-20150246937-A1 | ORGANOAMINOSILANES AND METHODS FOR MAKING SAME | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2015-09-03 | — | — | US | disclosed |
| EP-2913334-A1 | Organoaminosilanes and methods for making same | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2015-09-02 | — | — | EP | disclosed |
| EP-2860182-A2 | Organoaminosilane precursors and methods for depositing films comprising same | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2015-04-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150246937-A1 | ORGANOAMINOSILANES AND METHODS FOR MAKING SAME | DDAH1, IDUA, DDT | ADH1A 160/4885ADH1C 498/4885HRH4 753/4885 |
| US-20170204120-A1 | Organoaminosilanes and Methods for Making Same | DDAH1, IDUA, DDT | ADH1A 160/4885ADH1C 498/4885HRH4 753/4885 |
| US-20160168169-A1 | ORGANOAMINOSILANES AND METHODS FOR MAKING SAME | DDAH1, IDUA, DDT | ADH1A 160/4885ADH1C 498/4885HRH4 753/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.